Navigation Links
Contraceptive Patch Carries Risk of Blood clots

The U.S. Food and Drug Administration on Wednesday reported having updated the warning label on the Ortho Evra birth-control patch, cautioning users about the higher risk of blood clots from it.//

The drug manufacturer Johnson and Johnson’s commissioned study revealed that drug users faced two times the risk of clots in the legs and lungs compared to women taking traditional birth-control pills.

Another study commissioned by Johnson and Johnson, however, found no difference in risk between the patch and the pill. The FDA said, "Even though the results of the two studies are conflicting, the results of the second epidemiology study support FDA's concerns regarding the potential for Ortho Evra use to increase the risk of blood clots in some women."

Dr. Daniel Shames, the acting deputy director of FDA's Office of Drug Evaluation in the Center for Drug Evaluation and Research, said, "Blood clots occurring in the legs or lungs are serious and rare events that are a potential risk for all hormonal contraceptive therapies."

Shames said that risk factors for blood clots associated with contraceptives include smoking, inactivity, obesity, surgery and high doses.

The FDA has also required Johnson and Johnson to conduct a longer follow-up study of women using the patch to check for developments of heart attack, blood clots and stroke. Currently, the FDA believes the patch is safe for most women. Shames said, "Ortho Evra risk profile is acceptable for a highly effective contraceptive."

However the FDA’s concerns about the potential risk of blood clots in some women could not be ruled.

Earlier information that had been reported by Johnson and Johnson in a Feb. 16, 2006, press release was also included in the label change. This information was partly based, on an interim report from one of the two studies. The FDA said that the label change announced on Wednesday is based on the latest results from the two studies.

According to the label change women using the weekly patch which is the only birth-control patch approved by the FDA is taking in substantially more estrogen than women who take a daily birth-control pill. These pills typically contain 35 micrograms of estrogen. These higher levels of estrogen put some women at increased risk of blood clots.

Dr. Steven R. Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine said, "When the patch came out, I enthusiastically used [it] in women who don't like to take pills. But I thought that there was too much estrogen in it, because four of the women lasted one or two months and complained of symptoms, which are usually attributed to excess estrogen."

He added, "My advice is that for a patient who had been on the patch for any period of time and is doing well, I don't see a need to take her off. With most of the estrogen-related blood clots, the risk is greatest in the first six months of use."


NL
'"/>




Related medicine news :

1. Contraceptives via Internet
2. FDA Approves Contraceptive Ring
3. Contraceptives decreases Libido
4. Contraceptives have dual effects
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Contraceptive pill to reduce PMS
7. Smoking and Oral Contraceptives:
8. Contraceptive pills may lead to deformities in babies
9. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
10. Prevent Multiple Sclerosis From Oral Contraceptives
11. Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology: